Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06746675Not yet recruiting
Randomised, open-label trial in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Yale University. Primary endpoint: PrEP initiation at 6 months. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06746675.